Logo Image
|Articles|August 1, 2002

Supplements and Featured Publications

  • Measuring Persistency with Drug Therapy in Glaucoma Management
  • Volume 8
  • Issue 10 Suppl

An Economic Analysis of Switching to Latanoprost from a Beta-Blocker or adding Brimonidine or Latanoprost to a Beta-Blocker in Open-Angle Glaucoma or Ocular Hypertension

Download PDF: An Economic Analysis of Switching to Latanoprost from a Beta-Blocker or adding Brimonidine or Latanoprost to a Beta-Blocker in Open-Angle Glaucoma or Ocular Hypertension

Articles in this issue

almost 24 years ago

Measuring Patient Persistency with Drug Therapy Using Methods for the Design and Analysis of Natural History Studies

almost 24 years ago

Participating Faculty

almost 24 years ago

Introduction

almost 24 years ago

Population-Based Persistency Rates for Topical Glaucoma Medications Measured with Pharmacy Claims Data

almost 24 years ago

Rates of Discontinuation and Change of Glaucoma Therapy in a Managed Care Setting

almost 24 years ago

Dicontinuation Rates of Topical Glaucoma Medications in a Managed Care Population

almost 24 years ago

Measuring Persistency and Intraocular Pressure-Controlled Days in Patients Receiving Topical Glaucoma Medications

Related Content